Holcim Shares Jump After North America Spinoff Plan
By Adria Calatayud
Holcim shares jumped after the Swiss building-materials supplier unveiled plans to spin off its North America business, which could be valued at more than $30 billion.
At 0831 GMT on Monday, Holcim shares traded 5.7% higher to CHF67.92, taking the stock's gain over the last three months to more than 22%. This gave the company a market capitalization above 39 billion Swiss francs ($45.13 billion).
The company confirmed its plan to separate and take its North America unit public in the first half of 2025 after The Wall Street Journal reported the move.
Holcim also named its European head, Miljan Gutovic, as chief executive, to succeed Jan Jenisch, effective May 1.
News of the separation of Holcim's North American assets--which account for about 40% of the group's profit--came as a surprise, but the move seems smart, Berenberg analyst Harry Goad wrote in a note to clients.
"While not explicitly stated by management, we believe the clear rationale for such a move is to achieve a higher valuation for these U.S. assets, as they can be clearly valued against a U.S. peer group rather than when they reside within the global portfolio of the Switzerland-listed group," the Berenberg analyst said.
Write to Adria Calatayud at adria.calatayud@wsj.com
(END) Dow Jones Newswires
January 29, 2024 03:49 ET (08:49 GMT)
Copyright (c) 2024 Dow Jones & Company, Inc.-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
5 Stocks to Buy That We Still Like After They’ve Run Up
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track
-
American Airlines Earnings: We See Costs Overshadowing Market Share This Year
-
Snap Earnings: Advertising Growth and Snapchat+ Drive Monetization
-
STMicro Earnings: We Still See an Attractive Margin of Safety Despite a Poor First-Half Forecast
-
Alphabet Shares Surge on Strong Earnings, Dividend Surprise